Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+M2 Macrophages

被引:52
|
作者
Fujimura, Taku [1 ]
Kambayashi, Yumi [1 ]
Furudate, Sadanori [1 ]
Asano, Masayuki [1 ]
Kakizaki, Aya [1 ]
Aiba, Setsuya [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi 980, Japan
关键词
T-CELLS; DIFFERENTIATION; POLARIZATION;
D O I
10.1038/jid.2015.209
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:2884 / 2887
页数:4
相关论文
共 50 条
  • [31] Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages
    Fujimura, T.
    Kambayashi, Y.
    Furudate, S.
    Kakizaki, A.
    Asano, M.
    Aiba, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S74 - S74
  • [32] Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-κB and STAT1 activation in HaCaT cells
    Kwon, Dong-Joo
    Bae, Young-Soo
    Ju, Sung Mi
    Goh, Ah Ra
    Youn, Gi Soo
    Choi, Soo Young
    Park, Jinseu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (04) : 1254 - 1259
  • [33] Osteoprotegerin reduces the serum level of receptor activator of NF-κB ligand derived from osteoblasts
    Nakamichi, Yuko
    Udagawa, Nobuyuki
    Kobayashi, Yasuhiro
    Nakamura, Midrori
    Yamamoto, Yohei
    Yamashita, Teruhito
    Mizoguchi, Toshihide
    Sato, Masahiro
    Mogi, Makio
    Penninger, Josef M.
    Takahashi, Naoyuki
    JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 192 - 200
  • [34] Nrf2 activators inhibit osteoclastogenesis induced by receptor activator of NF-κB ligand
    Fumimoto, Reiko
    Sakamoto, Hiroshi
    Yamaguchi, Yu
    Sakai, Eiko
    Okamoto, Kuniaki
    Tsukuba, Takayuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 219P - 219P
  • [35] Expression and functional characterization of bovine receptor activator of NF-κB ligand (RANKL)
    Chapuis, Ambre F.
    Alfituri, Omar A.
    Hope, Jayne C.
    Stevens, Jo
    Moore, Jo
    Mclean, Kevin
    Androscuk, Dorota
    Dry, Inga
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2024, 268
  • [36] Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand
    Hikita, Atsuhiko
    Yana, Ikuo
    Wakeyama, Hidetoshi
    Nakamura, Masaki
    Kadono, Yuho
    Oshima, Yasushi
    Nakamura, Kozo
    Seiki, Motoharu
    Tanaka, Sakae
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (48) : 36846 - 36855
  • [37] Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-κB ligand
    Schneeweis, LA
    Willard, D
    Milla, ME
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (50) : 41155 - 41164
  • [38] Epigenetic control of mouse receptor activator of NF-κB ligand gene expression
    Kitazawa, S
    Kitazawa, R
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (01) : 126 - 131
  • [39] IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
    Palmqvist, P
    Persson, E
    Conaway, HH
    Lerner, UH
    JOURNAL OF IMMUNOLOGY, 2002, 169 (06): : 3353 - 3362
  • [40] Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-κB (NF-κB) ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvarial bones
    Swanson, Charlotte
    Lorentzon, Mattias
    Conaway, H. Herschel
    Lerner, Ulf H.
    ENDOCRINOLOGY, 2006, 147 (07) : 3613 - 3622